CRISPR/Cas9 and gene therapy

被引:0
作者
Giono, Luciana E. [1 ,2 ,3 ]
机构
[1] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina
[3] UBA, Fac Ciencias Exactas & Nat, Ciudad Univ,Pabellon 2, RA-1428 Buenos Aires, DF, Argentina
关键词
CRISPR/Cas9; genome editing; gene therapy; human embryos; IMMUNITY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of techniques that allow the precise and efficient edition of the genome of living cells is one of the main goals of biomedical research. Over the last few decades, a number of genome editing tools have been developed, the most prominent being the CRISPR/Cas9 system, a bacterial defense mechanism that has been redesigned for its use in other cellular systems. The accessibility, both technical and economical, and the enormous potential of CRISPR/Cas9 have contributed to an almost unprecedented revolution in the biomedical sciences and represent an important step forward in the field of gene therapy that needs, however, to be taken cautiously.
引用
收藏
页码:405 / 409
页数:5
相关论文
共 12 条
  • [1] A prudent path forward for genomic engineering and germline gene modification
    Baltimore, David
    Berg, Paul
    Botchan, Michael
    Carroll, Dana
    Charo, R. Alta
    Church, George
    Corn, Jacob E.
    Daley, George Q.
    Doudna, Jennifer A.
    Fenner, Marsha
    Greely, Henry T.
    Jinek, Martin
    Martin, G. Steven
    Penhoet, Edward
    Puck, Jennifer
    Sternberg, Samuel H.
    Weissman, Jonathan S.
    Yamamoto, Keith R.
    [J]. SCIENCE, 2015, 348 (6230) : 36 - 38
  • [2] May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells
    Brookhouser, Nicholas
    Raman, Sreedevi
    Potts, Christopher
    Brafman, David. A.
    [J]. CELLS, 2017, 6 (01)
  • [3] Multiplex Genome Engineering Using CRISPR/Cas Systems
    Cong, Le
    Ran, F. Ann
    Cox, David
    Lin, Shuailiang
    Barretto, Robert
    Habib, Naomi
    Hsu, Patrick D.
    Wu, Xuebing
    Jiang, Wenyan
    Marraffini, Luciano A.
    Zhang, Feng
    [J]. SCIENCE, 2013, 339 (6121) : 819 - 823
  • [4] The new frontier of genome engineering with CRISPR-Cas9
    Doudna, Jennifer A.
    Charpentier, Emmanuelle
    [J]. SCIENCE, 2014, 346 (6213) : 1077 - +
  • [5] ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
    Gaj, Thomas
    Gersbach, Charles A.
    Barbas, Carlos F., III
    [J]. TRENDS IN BIOTECHNOLOGY, 2013, 31 (07) : 397 - 405
  • [6] Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
    Gasiunas, Giedrius
    Barrangou, Rodolphe
    Horvath, Philippe
    Siksnys, Virginijus
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (39) : E2579 - E2586
  • [7] A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
    Jinek, Martin
    Chylinski, Krzysztof
    Fonfara, Ines
    Hauer, Michael
    Doudna, Jennifer A.
    Charpentier, Emmanuelle
    [J]. SCIENCE, 2012, 337 (6096) : 816 - 821
  • [8] The Heroes of CRISPR
    Lander, Eric S.
    [J]. CELL, 2016, 164 (1-2) : 18 - 28
  • [9] CRISPR, THE DISRUPTOR
    Ledford, Heidi
    [J]. NATURE, 2015, 522 (7554) : 20 - 24
  • [10] CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
    Liang, Puping
    Xu, Yanwen
    Zhang, Xiya
    Ding, Chenhui
    Huang, Rui
    Zhang, Zhen
    Lv, Jie
    Xie, Xiaowei
    Chen, Yuxi
    Li, Yujing
    Sun, Ying
    Bai, Yaofu
    Songyang, Zhou
    Ma, Wenbin
    Zhou, Canquan
    Huang, Junjiu
    [J]. PROTEIN & CELL, 2015, 6 (05) : 363 - 372